Home/Recalls/FDA-Z-1656-2026
FDA DevicesClass II

RefleXion X1 Radiotherapy System Model RXM1000, Part #800-00006-00

Published: April 8, 2026Recall ID: Z-1656-2026Category: devicesCountry: US

Reason for Recall / Hazard

Due to a radiotherapy medical system software defect, when performing angular roll corrections followed by a repeat localization, the roll corrections applied in the initial localization scan are not carried through to treatment delivery leading to the treatment plan dose being delivered to the incorrect location, potentially a displacement of 5mm or higher, with a 10% to 20% underdose.

Product Description & Identification

RefleXion X1 Radiotherapy System Model RXM1000, Part #800-00006-00

Additional Source Details

FieldValue
CityHayward
StateCA
Event id98518
Address 125881 Industrial Blvd
Code infoSoftware Version: 2.1.29-4 and Software Version: 2.1.35-1. UDI: (01)00860003983812(11)230504(21)X11001, (01)00860003983812(11)230518(21)X11002, (01)00860003983812(11)230505(21)X11003, (01)00860003983812(11)230530(21)X11004, (01)00860003983812(11)230811(21)X11006, (01)00860003983812(11)230410(21)X11007, (01)00860003983812(11)230803(21)X11008, (01)00860003983812(11)240528(21)X11009, (01)00860003983812(11)240820(21)X11010, (01)00860003983812(11)241107(21)X11011, (01)00860003983812(11)241206(21)X11012, (01)00860003983812(11)250731(21)X11013.
Postal code94545-2991
Report date20260408
Product typeDevices
Product quantity12
Reason for recallDue to a radiotherapy medical system software defect, when performing angular roll corrections followed by a repeat localization, the roll corrections applied in the initial localization scan are not carried through to treatment delivery leading to the treatment plan dose being delivered to the incorrect location, potentially a displacement of 5mm or higher, with a 10% to 20% underdose.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260209
Center classification date20260327

Overview

  • Recalling FirmReflexion Medical, Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionUS: CA, TX, PA, CT, NJ, OR, LA, OH
Official Agency Alert